Bas G. Van Rhijn

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Prediction of early (30-day) and late (30-90-day) mortality after radical cystectomy in a comprehensive cancer centre over two decades.

Prediction of early (30-day) and late (30-90-day) mortality after radical cystectomy in a comprehensive cancer centre over two decades.

Journal: World journal of urology

Published: July 03, 2019

Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future.

Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future.

Journal: Urologic oncology

Published: August 19, 2017

Extended pelvic lymph node dissection at radical cystectomy for bladder cancer improves survival: Results of a nationwide population-based study.

Extended pelvic lymph node dissection at radical cystectomy for bladder cancer improves survival: Results of a nationwide population-based study.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: October 05, 2016

Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.

Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 03, 2016

Variations in pelvic lymph node dissection in invasive bladder cancer: A Dutch nationwide population-based study during centralization of care.

Variations in pelvic lymph node dissection in invasive bladder cancer: A Dutch nationwide population-based study during centralization of care.

Journal: Urologic oncology

Published: January 16, 2016

Perioperative treatment and radical cystectomy for bladder cancer--a population based trend analysis of 10,338 patients in the Netherlands.

Perioperative treatment and radical cystectomy for bladder cancer--a population based trend analysis of 10,338 patients in the Netherlands.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 08, 2015

Molecular markers for urothelial bladder cancer prognosis: toward implementation in clinical practice.

Molecular markers for urothelial bladder cancer prognosis: toward implementation in clinical practice.

Journal: Urologic oncology

Published: January 03, 2014

Combining molecular and pathologic data to prognosticate non-muscle-invasive bladder cancer.

Combining molecular and pathologic data to prognosticate non-muscle-invasive bladder cancer.

Journal: Urologic oncology

Published: June 30, 2012

Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer.

Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer.

Journal: BJU international

Published: March 28, 2012

The FGFR3 mutation is related to favorable pT1 bladder cancer.

The FGFR3 mutation is related to favorable pT1 bladder cancer.

Journal: The Journal of urology

Published: April 04, 2011

Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer.

Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer.

Journal: European urology

Published: February 22, 2010

Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy.

Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy.

Journal: European urology

Published: June 06, 2009

Showing 1-12 of 13

Last Updated: 09/26/2026